Global Intravenous Solutions Market By Product (Total Parenteral Nutrition and Peripheral Parenteral Nutrition), By Nutrient (Carbohydrates, Parenteral Lipid Emulsion, and Others), By Region and Companies - Industry Segment Outlook, market Assessment, Competition Scenario, Trends and Forecast 2022-2032
- account_circleAbout Me
- 1. Intravenous Solutions Market Overview
- 2. Global Intravenous Solutions Market Analysis
- 3. Key market Segments:
- 4. market Dynamics:
- 5. Regional Analysis:
- 6. Key Regions and Countries covered in the report:
- 7. market Share & Key Players Analysis:
- 8. market Key Players:
Intravenous Solutions Market Overview
The global intravenous solutions market was worth USD 12.64 Billion in 2021. It is forecast to grow at a 7.6% CAGR.
This is due to an increase in natality, a rising geriatric population, and a higher prevalence of cancer. The production of intravenous IV (IV) solutions has increased significantly due to the COVID-19 pandemic. In the fight against COVID-19, intensive care units (ICUs), are crowded with COVID-19-infected patients. During the pandemic, there has been an increase in demand for intravenous shots.
Global Intravenous Solutions Market Analysis
In 2021, the Total parenteral nutrition segment (TPN), held the largest revenue share at 68.21%. The segment is expected to experience the fastest CAGR in the forecast year. This is due to an increase in gastrointestinal diseases such as Crohn’s Disease and Ulcerative Colitis. These diseases make it difficult for patients to absorb vital nutrients. Therefore, intravenous nutrients are used to deliver these nutrients to them. This can also be explained by an increase in the number of elderly patients who require intravenous nutrition.
The market can be divided into two segments based on its products: total parenteral nutrition (or peripheral parenteral) and peripheral nutrition (or both). The forecast year saw a steady CAGR for peripheral parental nutrition. When patients are unable to eat enough food but can tolerate some oral nutrition, the peripheral parental nutrition method is used. It is administered via hemlock, also known as a peripheral intravenous (PIL), and is only used for a brief time.
The peripheral access to it is easy to establish. This segment is driven by the increase in malnutrition throughout the world, which demands a sufficient supply of essential nutrients to sustain health.
The global market was further divided by nutrients into single-dose amino acids solution, carbohydrates, vitamins & minerals, parenteral lip emulsion, and others. In 2021, the single-dose segment of amino acid solutions accounted for 28.5% of the total revenue. This market is known for its growth characteristics. Patients who have significantly increased their protein needs due to severe burns or gastrointestinal problems can be given a single dose of amino acid solution.
Undernourished people can also be given single-dose amino acid combinations with vitamins, dextrose, or trace elements. The fastest CAGR is expected to be in the vitamins and minerals (salt & electrolyte), a segment during the forecast period. Malnutrition is a condition that causes weak bones, fatigue, and impaired immune systems. It can also be used to treat pellagra, anemia, chronic mental disorders, and beriberi. The market can be divided into nutrients: vitamins & minerals; single-dose amino acid; parenteral liquid emulsion; and carbohydrates. Other segments include iron, cobalt, zinc (in the form of vitamin B12), and iodine.
Key market Segments:
- Total Parenteral Nutrition
- Peripheral Parenteral Nutrition
- Parenteral Lipid Emulsion
- Vitamins and Minerals
- Single Dose Amino Acids
- Other Nutrients
The new coronavirus strains are being reported in different parts of the globe, resulting in more people getting the virus. The result is an increase in hospital admissions. Patients with severe lung infections and the elderly are often placed on ventilators to provide critical care. Patients with severe lung infections and the elderly are often placed on ventilators to ensure adequate nutrition. The WHO recommends that COVID-19 patients suffering from severe respiratory infections need intravenous fluids. The demand for IV solutions is expected to rise significantly during the pandemic.
Significant demand exists for modern medical care due to the increase in life expectancy and surgical procedures. IV nutrition is an integral part of any treatment. It helps patients to meet their nutritional requirements and heal faster. The Total Parenteral Nutrition approach (TPN), is used when patients are unable or unwilling to take nutritional solutions via the oral or enteral routes.
Parenteral nutrition is becoming more popular due to the rising incidence of chronic conditions like cancer. Parenteral Nutrition is a vital source of nutrients that helps patients with chronic diseases maintain their strength, energy, and hydration. According to statistics from the WHO, there will be approximately 10 million cancer-related deaths in 2020. In the next few decades, an estimated 70.0% rise in cancer cases will be observed. market growth will be aided by the increasing incidence of cancer.
The global market can be divided into North America and Europe based on their geography. In 2021, North America was the dominant market and held 42.3% of the total revenue. This is due to an increase in the number of elderly people, which leads to an increased demand for intravenous products, an increasing prevalence of chronic illnesses, and industry expansion to meet the growing demands.
The fastest CAGR is expected to be in the Asia-Pacific region during the forecast period. This region’s high growth can be attributed to high research expenditures by both public and private entities, technological advances, and increasing collaborations among various stakeholders such as the medical fraternity and universities. The Asia Pacific region is expected to grow due to the rising incidence of chronic diseases and the demand for affordable care treatments.
Key Regions and Countries covered in the report:
- North America
- Rest of Europe
- South Korea
- Rest of Asia-Pacific
- South America
- Rest of South America
- South Africa
- Rest of MEA
These players are constantly expanding their facilities and engaging in acquisitions and collaborations with other companies. They also participate in product development. These key strategic initiatives are changing the industry dynamics. ICU Medical, a subsidiary of Smiths Group plc, acquired Smiths Medical in 2022. The acquisition will bring together the ambulatory and vascular access devices, syringes, vascular access, and vital care products from Smiths Medical into ICU Medical’s existing infusion therapy system. The following are some of the major players in the global intravenous solution market.
market Key Players:
- Fresenius Kabi AG
- Pfizer, Inc.
- Otsuka Pharmaceutical Co., Ltd.
- B. Braun Melsungen AG
- Vifor Pharma Management Ltd.
- JW Life Science
- Amanta Healthcare
- ICU Medical Inc.
- Grifols, S.A.
- Other Key Players
For the Intravenous Solutions Market research study, the following years have been considered to estimate the market size:
Attribute Report Details
Market Size in 2022
Forecast Value in 2032
Short Term Projection Year
Long Term Projection Year
Competitive Landscape, Revenue analysis, Company Share Analysis, Manufacturers Analysis, Volume by Manufacturers, Key Segments, Key company analysis, Market Trends, Distribution Channel, Market Dynamics, COVID-19 Impact Analysis, strategy for existing players to grab maximum market share, and more.
North America, Europe, Asia-Pacific, South America, Middle East & Africa
United States, Canada and Mexico, Germany, France, UK, Russia and Italy, China, Japan, Korea, India and Southeast Asia, Brazil, Argentina, Colombia etc.Saudi Arabia, UAE, Egypt, Nigeria and South Africa
Frequently Asked Questions (FAQ)
What is the size of the intravenous solutions market in 2021?
The intravenous solutions market size is US$ 12,641 million in 2021.
What is the projected CAGR at which the intravenous solutions market is expected to grow at?
The intravenous solutions market is expected to grow at a CAGR of 7.6% (2023-2032).
List the segments encompassed in this report on the intravenous solutions market?
market.US has segmented the intravenous solutions market by geographic (North America, Europe, APAC, South America, and Middle East and Africa). By Product, the market has been further divided into Total Parenteral Nutrition and Peripheral Parenteral Nutrition. By Nutrient, the market has been further divided into Carbohydrates Parenteral Lipid Emulsion, Vitamins and Minerals, Single Dose Amino Acids, and Other Nutrients.
List the key industry players of the intravenous solutions market?
Fresenius Kabi AG, Pfizer, Inc., Otsuka Pharmaceutical Co., Ltd., Baxter, B. Braun Melsungen AG, Vifor Pharma Management Ltd., JW Life Science, Amanta Healthcare, ICU Medical Inc., Grifols, S.A., and Other Key Players engaged in the Intravenous Solutions market.
Which region is more appealing for vendors employed in the intravenous solutions market?
North America is expected to account for the highest revenue share of 42.3%. Therefore, the intravenous solutions industry in North America is expected to garner significant business opportunities over the forecast period.
Name the key areas of business for intravenous solutions?
The US, India, China, Canada, UK, Japan, & Germany are key areas of operation for the intravenous solutions market.
Which segment accounts for the greatest market share in the intravenous solutions industry?
With respect to the intravenous solutions industry, vendors can expect to leverage greater prospective business opportunities through the total parenteral nutrition segment, as this area of interest accounts for the largest market share.
- account_circleAbout Me
Request a Sample ReportWe'll get back to you as quickly as possible
USD / per unit
USD / per unit
USD / per unit
|Report Library Access|
|Data Set (Excel)|
|Company Profile Library Access|
|Free Custumization||No||up to 10 hrs work||up to 30 hrs work|
|Accessibility||1 User||2-5 User||Unlimited|
|Analyst Support||up to 20 hrs||up to 40 hrs||up to 50 hrs|
|Benefit||Up to 20% off on next purchase||Up to 25% off on next purchase||Up to 30% off on next purchase|